GAS2 and acute lymphoblastic leukemia: To determine whether GAS2 is a suitable therapeutic target for T‐ALL, floxed and Vav‐iCre mice were crossed to study the effect of Gas2 loss on normal murine hematopoiesis (Fig. 7A).